The death of a third patient tied to a Sarepta Therapeutics gene therapy this year sent the company’s shares nosediving 36% Friday, halting the momentum the stock generated just a day earlier after ...

In multiple experiments, C-a16 lipids, which contain a phenol group, outperformed LNPs used in currently available mRNA ...

Using machine learning, OmicsTweezer merges diverse data by using deep learning combined with optimal transport.

GenesisM’s enhanced core platform is designed to provide long-term operational flexibility and accelerate buildout timeline.

Sarepta Therapeutics said it will eliminate 36% of its workforce—approximately 500 jobs—in a restructuring that follows the ...

ImP administration to mouse model induced atherosclerosis without altering the lipid profile, and was associated with immune ...

Thermo Fisher will expand use of the Sanofi site to meet the demand from pharma and biotech customers for U.S. manufacturing capacity.

David Baker’s lab has successfully designed binders to disordered proteins, expanding therapeutic access to over 50% of the human proteome.

Eight babies, born following Mitochondrial Donation treatment to reduce transmission of mitochondrial DNA disease, show no ...

Researchers developed a benchtop bioreactor that can handle mL to liters. Instead of a shaft-driven stirrer, this bioreactor uses levitation.

The portrayal of uncaring scientists without any thought for the animals being used in their research is far from the truth.

The acquisition of Avivia aligns with Ofichem’s broader merger and acquisition agenda and ongoing investment strategy.